Wockhardt gets US nod for Levofloxacin
New Delhi: Pharmaceutical major Wockhardt has received tentative approval from the US Food and Drug Administration (FDA) for marketing the 250 mg, 500 mg and 750 mg tablets of Levofloxacin, used for treatment of bacterial infections.
Levofloxacin is the generic name for the brand Levaquin, marketed in the US by Ortho Mcneil (Johnson & Johnson). Wockhardt will launch the product immediately upon expiration of the patent on June 20, 2011, the company said in a statement.
Levofloxacin is a very widely used antibacterial drug and belongs to the fluoroquinolone group. The total market for Levofloxacin tablets in the US is about $1.6 billion.
“Ability to launch products on the date of patent expiration is the most critical element of success in the highly competitive US generics market,” said Wockhardt chairman Habil Khorakiwala.
“Receiving the tentative approval will enable Wockhardt to plan a successful launch of Levofloxacin in the US. We have had a good start to the year 2010, with two tentative approvals in as many weeks,” he added.
The Levofloxacin tablets will be manufactured at the US FDA certified formulation plant at Waluj, Aurangabad, the company said.
More from India
More from World
More from Sports
More from Entertaiment
- Will Akhilesh-Rahul alliance be able to trump BJP in UP elections?
- Arms case: Salman Khan acquitted by Jodhpur court
- Raisina Dialogue 2017: Pakistan must walk away from terror, says PM Modi
- DNA: Analysis of insensitivity shown by political leaders over rising poverty in India
- Are separatists scared with 'Dangal' girl Zaira Wasim's success?
- World's 30 most dynamic cities: Check out the full list
- WATCH: Kieron Pollard's incredible one-handed six demoralises Fawad Ahmed
- Virat Kohli's 'shot of the year' already has a big challenger – See video to believe!
- China State TV said that its troops can reach New Delhi in 48 hours in war scenario; Indians slay it with their replies
- Bengaluru pips Silicon Valley to become world's most dynamic city